174 related articles for article (PubMed ID: 38252148)
21. LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/β-catenin signaling.
Liang WC; Ren JL; Wong CW; Chan SO; Waye MM; Fu WM; Zhang JF
Oncogene; 2018 Mar; 37(11):1445-1456. PubMed ID: 29311643
[TBL] [Abstract][Full Text] [Related]
22. May we challenge the ENETS guidelines in pancreatic neuroendocrine neoplasms? A quiz for French experts.
Brieau B; Coriat R
Dig Liver Dis; 2017 Jul; 49(7):809-819. PubMed ID: 28377287
[TBL] [Abstract][Full Text] [Related]
23. microRNA-211-mediated targeting of the INHBA-TGF-β axis suppresses prostate tumor formation and growth.
Zhao Z; Wang K; Tan S
Cancer Gene Ther; 2021 May; 28(5):514-528. PubMed ID: 33223523
[TBL] [Abstract][Full Text] [Related]
24. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
Song Y; Washington MK; Crawford HC
Cancer Res; 2010 Mar; 70(5):2115-25. PubMed ID: 20160041
[TBL] [Abstract][Full Text] [Related]
25. Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation.
de Vries C; Konukiewitz B; Weichert W; Klöppel G; Aupperle-Lellbach H; Steiger K
J Comp Pathol; 2020 Nov; 181():73-85. PubMed ID: 33288156
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors.
Simon T; Riemer P; Jarosch A; Detjen K; Di Domenico A; Bormann F; Menne A; Khouja S; Monjé N; Childs LH; Lenze D; Leser U; Rossner F; Morkel M; Blüthgen N; Pavel M; Horst D; Capper D; Marinoni I; Perren A; Mamlouk S; Sers C
Genome Med; 2022 Mar; 14(1):24. PubMed ID: 35227293
[TBL] [Abstract][Full Text] [Related]
27. Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.
Andreasi V; Muffatti F; Guarneri G; Falconi M; Partelli S
Curr Treat Options Oncol; 2020 Apr; 21(6):48. PubMed ID: 32350693
[TBL] [Abstract][Full Text] [Related]
28. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
Pipinikas CP; Berner AM; Sposito T; Thirlwell C
Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410
[TBL] [Abstract][Full Text] [Related]
29. Translational regulation of inhibin βA by TGFβ via the RNA-binding protein hnRNP E1 enhances the invasiveness of epithelial-to-mesenchymal transitioned cells.
Howley BV; Hussey GS; Link LA; Howe PH
Oncogene; 2016 Mar; 35(13):1725-35. PubMed ID: 26096938
[TBL] [Abstract][Full Text] [Related]
30. iPSC-Derived Pancreatic Progenitors Lacking FOXA2 Reveal Alterations in miRNA Expression Targeting Key Pancreatic Genes.
Aldous N; Elsayed AK; Alajez NM; Abdelalim EM
Stem Cell Rev Rep; 2023 May; 19(4):1082-1097. PubMed ID: 36749553
[TBL] [Abstract][Full Text] [Related]
31. The tumor suppressive role of inhibin βA in diffuse large B-cell lymphoma.
Jiang L; Si T; Yu M; Zeng X; Morse HC; Lu Y; Ouyang G; Zhou JX
Leuk Lymphoma; 2018 May; 59(5):1202-1212. PubMed ID: 28877610
[TBL] [Abstract][Full Text] [Related]
32. Race and Odds of Surgery Offer in Small Bowel and Pancreas Neuroendocrine Neoplasms.
Zarate Rodriguez JG; Raper L; Sanford DE; Trikalinos NA; Hammill CW
Ann Surg Oncol; 2024 May; 31(5):3249-3260. PubMed ID: 38294612
[TBL] [Abstract][Full Text] [Related]
33. Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.
Tachibana T; Kasajima A; Aoki T; Tabata T; McNamara K; Yazdani S; Satoko S; Fujishima F; Motoi F; Unno M; Sasano H
J Steroid Biochem Mol Biol; 2020 Jul; 201():105694. PubMed ID: 32437964
[TBL] [Abstract][Full Text] [Related]
34. FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner.
Milan M; Balestrieri C; Alfarano G; Polletti S; Prosperini E; Spaggiari P; Zerbi A; Diaferia GR; Natoli G
EMBO J; 2019 Oct; 38(20):e102161. PubMed ID: 31531882
[TBL] [Abstract][Full Text] [Related]
35. Prognostic relevance of proliferation-related miRNAs in pancreatic neuroendocrine neoplasms.
Grolmusz VK; Kövesdi A; Borks K; Igaz P; Patócs A
Eur J Endocrinol; 2018 Oct; 179(4):219-228. PubMed ID: 30299890
[TBL] [Abstract][Full Text] [Related]
36. LncRNA INHBA-AS1 promotes colorectal cancer cell proliferation by sponging miR-422a to increase AKT1 axis.
Lin H; Hong YG; Zhou JD; Gao XH; Yuan PH; Xin C; Huang ZP; Zhang W; Hao LQ; Hou KZ
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9940-9948. PubMed ID: 33090398
[TBL] [Abstract][Full Text] [Related]
37. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development.
Gao N; LeLay J; Vatamaniuk MZ; Rieck S; Friedman JR; Kaestner KH
Genes Dev; 2008 Dec; 22(24):3435-48. PubMed ID: 19141476
[TBL] [Abstract][Full Text] [Related]
38. M2-phenotype tumour-associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer.
Liang ZW; Yu J; Gu DM; Liu XM; Liu J; Wu MY; Xu MD; Shen M; Duan W; Li W
J Cell Mol Med; 2022 Mar; 26(5):1540-1555. PubMed ID: 35150061
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.
Bocchini M; Nicolini F; Severi S; Bongiovanni A; Ibrahim T; Simonetti G; Grassi I; Mazza M
Front Oncol; 2020; 10():831. PubMed ID: 32537434
[TBL] [Abstract][Full Text] [Related]
40. Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas.
Bonnavion R; Teinturier R; Gherardi S; Leteurtre E; Yu R; Cordier-Bussat M; Du R; Pattou F; Vantyghem MC; Bertolino P; Lu J; Zhang CX
J Pathol; 2017 May; 242(1):90-101. PubMed ID: 28188614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
